Microtubule-Associated Protein ATIP3, an Emerging Target for Personalized Medicine in Breast Cancer
Breast cancer is the leading cause of death by malignancy among women worldwide. Clinical data and molecular characteristics of breast tumors are essential to guide clinician’s therapeutic decisions. In the new era of precision medicine, that aims at personalizing the treatment for each patient, the...
Main Authors: | Maria M. Haykal, Sylvie Rodrigues-Ferreira, Clara Nahmias |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-05-01
|
Series: | Cells |
Subjects: | |
Online Access: | https://www.mdpi.com/2073-4409/10/5/1080 |
Similar Items
-
The Tumor Suppressor <i>MTUS1</i>/ATIP1 Modulates Tumor Promotion in Glioma: Association with Epigenetics and DNA Repair
by: Nikhil Ranjan, et al.
Published: (2021-03-01) -
La protéine ATIP3 et ses partenaires d’interaction : de nouvelles cibles thérapeutiques contre le cancer du sein
by: Nehlig, Anne
Published: (2018) -
Molecular Biomarkers for Contemporary Therapies in Hormone Receptor-Positive Breast Cancer
by: Allegra Freelander, et al.
Published: (2021-02-01) -
Expression of tumor suppressors miR-195 and let-7a as potential biomarkers of invasive breast cancer
by: Marcia M. Marques, et al.
Published: (2018-07-01) -
Personalized Medicine—Current and Emerging Predictive and Prognostic Biomarkers in Colorectal Cancer
by: Christine Koulis, et al.
Published: (2020-03-01)